Medicine Man Technologies, Inc. (SHWZ)
OTCMKTS · Delayed Price · Currency is USD
0.00001
0.00 (0.00%)
Aug 27, 2026, 4:00 PM EST
Medicine Man Technologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 0 | 44 | 77 | 80 | 62 | 107 | |
Market Cap Growth | -90.00% | -43.64% | -2.79% | 27.59% | -41.65% | 208.14% |
Enterprise Value | - | 207 | 183 | 121 | 61 | 92 |
Last Close Price | 0.00 | 0.61 | 1.42 | 1.77 | 1.49 | 2.68 |
Price Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PE Ratio | - | - | - | 11.11 | - | - |
Forward PE | - | 82.40 | 17.92 | 4.20 | - | - |
PS Ratio | 0.00 | 0.25 | 0.49 | 0.74 | 2.60 | 10.08 |
PB Ratio | 0.00 | 0.37 | 0.59 | 0.60 | 1.50 | 4.03 |
P/TBV Ratio | - | - | - | - | - | 7.54 |
P/FCF Ratio | 0.13 | 10.07 | - | 28.89 | - | - |
P/OCF Ratio | 0.03 | 3.58 | 11.58 | 9.49 | - | - |
EV Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
EV/Sales Ratio | - | 1.20 | 1.15 | 1.12 | 2.53 | 8.66 |
EV/EBITDA Ratio | - | 7.95 | 5.82 | 6.39 | - | - |
EV/EBIT Ratio | - | 40.66 | 8.79 | 11.65 | - | - |
EV/FCF Ratio | - | 47.74 | - | 43.94 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Debt / Equity Ratio | 2.18 | 1.61 | 1.12 | 0.80 | 0.52 | 0.00 |
Debt / EBITDA Ratio | 17.68 | 7.37 | 4.70 | 5.23 | - | - |
Debt / FCF Ratio | 155.04 | 44.26 | - | 38.53 | - | - |
Net Debt / Equity Ratio | 2.05 | 1.44 | 0.82 | 0.00 | 0.48 | -0.46 |
Net Debt / EBITDA Ratio | 16.57 | 6.62 | 3.45 | -0.03 | -0.89 | 0.90 |
Net Debt / FCF Ratio | 145.35 | 39.71 | -14.88 | -0.20 | -1.90 | 1.57 |
Asset Turnover | 0.49 | 0.51 | 0.52 | 0.61 | 0.47 | 0.42 |
Inventory Turnover | 3.64 | 3.99 | 4.70 | 8.60 | 10.43 | 12.97 |
Quick Ratio | 0.19 | 0.43 | 0.93 | 2.45 | 0.21 | 2.20 |
Current Ratio | 0.54 | 0.97 | 1.51 | 2.75 | 0.49 | 2.79 |
Return on Equity (ROE) | -49.97% | -27.48% | -13.90% | 16.56% | -56.81% | -77.77% |
Return on Assets (ROA) | -1.93% | 0.93% | 4.29% | 3.66% | -27.82% | -33.73% |
Return on Invested Capital (ROIC) | -3.90% | 1.91% | 11.16% | 8.19% | -59.58% | -86.32% |
Return on Capital Employed (ROCE) | -4.30% | 1.70% | 7.60% | 4.30% | -39.30% | -51.10% |
Yields
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Earnings Yield | -39633.64% | -79.11% | -23.83% | 18.21% | -31.08% | -15.85% |
FCF Yield | 746.61% | 9.93% | -9.44% | 3.46% | -16.91% | -7.24% |
Buyback Yield / Dilution | -28.04% | -20.32% | 47.09% | -145.94% | -22.16% | -21.50% |